Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Masuda

Showing results (181-190 of 277) with videos related to

Pageof 28
Sort By:
Nihon Kyobu Shikkan Gakkai Zasshi|April 1, 1993
[Systemic chemotherapy for brain metastasis from small cell lung cancer]H Tanaka, N Takifuji, N Masuda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Phase I study of irinotecan and cisplatin with granulocyte colony-stimulating factor support for advanced non-small-cell lung cancerN Masuda, M Fukuoka, S Kudoh, et al.
British Journal of Cancer|August 14, 1998
Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: the role of smoking cessationM Kawahara, S Ushijima, T Kamimori, et al.
British Journal of Cancer|July 3, 2003
FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinomaT Miyazaki, H Kato, M Nakajima, et al.
British Journal of Cancer|February 6, 2003
Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancerS Negoro, N Masuda, Y Takada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancerN Masuda, M Fukuoka, S Kudoh, et al.
American Journal of Clinical Oncology|August 1, 1991
Redevelopment of small-cell lung cancer nine years after the start of therapy. A case report and review of the literatureN Masuda, M Fukuoka, M Takada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lungT Komiya, Y Hosono, T Hirashima, et al.
Anticancer Research|February 19, 2002
Expression of nitrotyrosine is associated with angiogenesis in esophageal squamous cell carcinomaH Kato, T Miyazaki, M Yoshikawa, et al.
Cancer|June 15, 1990
Evaluation of high-dose etoposide combined with cisplatin for treating relapsed small cell lung cancerN Masuda, M Fukuoka, K Matsui, et al.
Pageof 28

Showing results (181-190 of 277) with videos related to

Sort By:
Pageof 28
Nihon Kyobu Shikkan Gakkai Zasshi|April 1, 1993
[Systemic chemotherapy for brain metastasis from small cell lung cancer]H Tanaka, N Takifuji, N Masuda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Phase I study of irinotecan and cisplatin with granulocyte colony-stimulating factor support for advanced non-small-cell lung cancerN Masuda, M Fukuoka, S Kudoh, et al.
British Journal of Cancer|August 14, 1998
Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: the role of smoking cessationM Kawahara, S Ushijima, T Kamimori, et al.
British Journal of Cancer|July 3, 2003
FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinomaT Miyazaki, H Kato, M Nakajima, et al.
British Journal of Cancer|February 6, 2003
Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancerS Negoro, N Masuda, Y Takada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancerN Masuda, M Fukuoka, S Kudoh, et al.
American Journal of Clinical Oncology|August 1, 1991
Redevelopment of small-cell lung cancer nine years after the start of therapy. A case report and review of the literatureN Masuda, M Fukuoka, M Takada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lungT Komiya, Y Hosono, T Hirashima, et al.
Anticancer Research|February 19, 2002
Expression of nitrotyrosine is associated with angiogenesis in esophageal squamous cell carcinomaH Kato, T Miyazaki, M Yoshikawa, et al.
Cancer|June 15, 1990
Evaluation of high-dose etoposide combined with cisplatin for treating relapsed small cell lung cancerN Masuda, M Fukuoka, K Matsui, et al.
Pageof 28